Laird Norton Wetherby Wealth Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $329K | Buy |
3,338
+55
| +2% | +$5.45K | 0.01% | 722 |
|
|
2025
Q2 | $299K | Buy |
+3,283
| New | +$317K | 0.01% | 722 |
|
|
2024
Q4 | $414K | Sell |
3,920
-196
| -5% | -$21K | 0.02% | 600 |
|
|
2024
Q3 | $444K | Sell |
4,116
-610
| -13% | -$66.6K | 0.02% | 605 |
|
|
2024
Q2 | $513K | Sell |
4,726
-449
| -9% | -$52.9K | 0.02% | 529 |
|
|
2024
Q1 | $683K | Buy |
5,175
+4
| +0.1% | +$500 | 0.03% | 463 |
|
|
2023
Q4 | $629K | Buy |
5,171
+241
| +5% | +$26.9K | 0.03% | 463 |
|
|
2023
Q3 | $553K | Sell |
4,930
-75
| -1% | -$9.52K | 0.03% | 485 |
|
|
2023
Q2 | $729K | Sell |
5,005
-57
| -1% | -$7.75K | 0.04% | 423 |
|
|
2023
Q1 | $654K | Buy |
5,062
+72
| +1% | +$9.04K | 0.04% | 445 |
|
|
2022
Q4 | $636K | Buy |
4,990
+57
| +1% | +$6.62K | 0.04% | 438 |
|
|
2022
Q3 | $516K | Sell |
4,933
-793
| -14% | -$87K | 0.04% | 478 |
|
|
2022
Q2 | $602K | Buy |
5,726
+643
| +13% | +$76.3K | 0.04% | 437 |
|
|
2022
Q1 | $650K | Sell |
5,083
-380
| -7% | -$45.8K | 0.04% | 429 |
|
|
2021
Q4 | $674K | Sell |
5,463
-476
| -8% | -$62.3K | 0.04% | 415 |
|
|
2021
Q3 | $844K | Sell |
5,939
-85
| -1% | -$12.5K | 0.05% | 343 |
|
|
2021
Q2 | $941K | Buy |
6,024
+24
| +0.4% | +$3.89K | 0.06% | 318 |
|
|
2021
Q1 | $932K | Sell |
6,000
-68
| -1% | -$10.5K | 0.07% | 273 |
|
|
2020
Q4 | $908K | Sell |
6,068
-283
| -4% | -$40K | 0.06% | 294 |
|
|
2020
Q3 | $839K | Buy |
6,351
+956
| +18% | +$125K | 0.07% | 254 |
|
|
2020
Q2 | $626K | Buy |
5,395
+321
| +6% | +$37K | 0.06% | 312 |
|
|
2020
Q1 | $498K | Buy |
5,074
+1,431
| +39% | +$188K | 0.06% | 322 |
|
|
2019
Q4 | $530K | Sell |
3,643
-1,530
| -30% | -$211K | 0.05% | 390 |
|
|
2019
Q3 | $689K | Buy |
5,173
+91
| +2% | +$11.8K | 0.07% | 304 |
|
|
2019
Q2 | $581K | Buy |
5,082
+231
| +5% | +$27.1K | 0.06% | 344 |
|
|
2019
Q1 | $602K | Sell |
4,851
-119
| -2% | -$13.5K | 0.08% | 317 |
|
|
2018
Q4 | $501K | Sell |
4,970
-186
| -4% | -$20.9K | 0.07% | 329 |
|
|
2018
Q3 | $658K | Buy |
5,156
+3
| +0.1% | +$357 | 0.08% | 282 |
|
|
2018
Q2 | $558K | Sell |
5,153
-397
| -7% | -$43.2K | 0.08% | 311 |
|
|
2018
Q1 | $587K | Buy |
5,550
+111
| +2% | +$12.9K | 0.08% | 296 |
|
|
2017
Q4 | $637K | Buy |
5,439
+117
| +2% | +$13.2K | 0.09% | 276 |
|
|
2017
Q3 | $605K | Sell |
5,322
-136
| -2% | -$15.7K | 0.09% | 284 |
|
|
2017
Q2 | $680K | Sell |
5,458
-8
| -0.1% | -$948 | 0.12% | 225 |
|
|
2017
Q1 | $648K | Sell |
5,466
-213
| -4% | -$24.1K | 0.12% | 226 |
|
|
2016
Q4 | $569K | Sell |
5,679
-224
| -4% | -$24K | 0.11% | 239 |
|
|
2016
Q3 | $745K | Buy |
5,903
+68
| +1% | +$8.4K | 0.15% | 166 |
|
|
2016
Q2 | $682K | Sell |
5,835
-160
| -3% | -$18.1K | 0.15% | 164 |
|
|
2016
Q1 | $620K | Buy |
5,995
+618
| +11% | +$59.8K | 0.15% | 165 |
|
|
2015
Q4 | $536K | Buy |
5,377
+7
| +0.1% | +$685 | 0.13% | 186 |
|
|
2015
Q3 | $489K | Buy |
5,370
+445
| +9% | +$44.6K | 0.13% | 198 |
|
|
2015
Q2 | $522K | Buy |
4,925
+490
| +11% | +$54.2K | 0.13% | 199 |
|
|
2015
Q1 | $507K | Buy |
4,435
+129
| +3% | +$14.7K | 0.12% | 200 |
|
|
2014
Q4 | $474K | Sell |
4,306
-95
| -2% | -$10K | 0.12% | 197 |
|
|
2014
Q3 | $429K | Buy |
4,401
+53
| +1% | +$5.21K | 0.12% | 208 |
|
|
2014
Q2 | $439K | Buy |
4,348
+21
| +0.5% | +$2.05K | 0.12% | 202 |
|
|
2014
Q1 | $397K | Buy |
4,327
+25
| +0.6% | +$2.3K | 0.11% | 223 |
|
|
2013
Q4 | $389K | Sell |
4,302
-5
| -0.1% | -$433 | 0.11% | 232 |
|
|
2013
Q3 | $344K | Buy |
4,307
+62
| +1% | +$4.88K | 0.11% | 240 |
|
|
2013
Q2 | $309K | Buy |
+4,245
| New | +$317K | 0.11% | 226 |
|
Other funds holding ZBH
Laird Norton Wetherby Wealth Management's ZBH Position: Q3 2025 in Review
Laird Norton Wetherby Wealth Management increased its Zimmer Biomet (ZBH) stake by 1.7% in Q3 2025, buying an estimated $5.45K and bringing the position to 3,338 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #722.
Laird Norton Wetherby Wealth Management first reported a position in ZBH in Q2 2013 and has held it in 49 quarters since. The position peaked at $941K in Q2 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Laird Norton Wetherby Wealth Management held 3,338 shares of Zimmer Biomet worth $329K as of Q3 2025.
- Laird Norton Wetherby Wealth Management bought 55 Zimmer Biomet shares in Q3 2025, an estimated $5.45K.
- Zimmer Biomet made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #722 holding.
- Laird Norton Wetherby Wealth Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 49 quarters since.
- Laird Norton Wetherby Wealth Management's Zimmer Biomet position peaked at $941K in Q2 2021.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.